GlaxoSmithKline PLC — Director's Dealing 2018

Jul 17, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9419U

GlaxoSmithKline PLC

17 July 2018

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr D E Troy

b)

Position/status

SVP & General Counsel

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

American Depositary Shares ('ADSs')

ISIN: US37733W1053

b)

Nature of the transaction

Acquisition of ADSs following the re-investment of dividends paid to shareholders on 12 July 2018 on ADSs held in the Company's US Deferred Performance Share Plan.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
$41.75	5.992
$41.75	388.800

d)

Aggregated information

Aggregated volume Price

394.792

$41.75

e)

Date of the transaction

2018-07-12

f)

Place of the transaction

New York Stock Exchange (XYNS)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHEDLFFVDFEBBB